Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression

被引:155
|
作者
Agoulnik, IU
Vaid, A
Bingman, WE
Erdeme, H
Frolov, A
Smith, CL
Ayala, G
Ittmann, MM
Weigel, NL
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Urol, Houston, TX 77030 USA
关键词
D O I
10.1158/0008-5472.CAN-04-3541
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate cancer is initially androgen dependent and there is evidence that androgen receptor continues to play a role in androgen-independent prostate cancer. Androgen receptor activity depends both on the level of androgens and on the level of coactivators that interact with androgen receptor. Our goal was to evaluate the role of the androgen receptor coactivator SRC-l in prostate cancer progression. Using tissue arrays to measure SRC-I protein levels, we found that increased SRC-1 expression in clinically localized, androgen-dependent cancer is associated with clinical and pathologic variables of increased tumor aggressiveness. Interestingly, there was variable expression of SRC-1 in normal prostate tissue which correlated with the staining intensity of the corresponding cancer tissue. To test the contribution of SRC-1, we examined its role in androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer cell lines. Using small interfering RNA to reduce expression of androgen receptor, we found that androgen receptor was required both for cell growth and for basal expression of prostate-specific antigen in the androgen-independent C4-2 cell line. Thus, although the cells can grow in an androgen-depleted medium, they remained androgen receptor dependent. Reduction of SRC-1 expression significantly reduced growth and altered androgen receptor target gene regulation in both LNCaP and C4-2 cell lines whereas it had no effect on the growth of the androgen receptor-negative PC-3 and DU145 prostate cancer cell lines. Although the requirement for androgens and androgen receptor in the development of prostate cancer is well established, our study implicates enhanced androgen receptor activity through elevated expression of SRC-I in the development of more aggressive disease in men with prostate cancer.
引用
收藏
页码:7959 / 7967
页数:9
相关论文
共 50 条
  • [1] The role of connexins in prostate cancer promotion and progression
    Czyz, Jaroslaw
    Szpak, Katarzyna
    Madeja, Zbigniew
    NATURE REVIEWS UROLOGY, 2012, 9 (05) : 274 - 282
  • [2] The role of prostate tumor overexpressed 1 in cancer progression
    Canovas, Veronica
    Lleonart, Matilde
    Morote, Juan
    Paciucci, Rosanna
    ONCOTARGET, 2017, 8 (07) : 12451 - 12471
  • [3] The role of connexins in prostate cancer promotion and progression
    Jarosław Czyż
    Katarzyna Szpak
    Zbigniew Madeja
    Nature Reviews Urology, 2012, 9 : 274 - 282
  • [4] Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth
    Nhat D. Quach
    Sukhneeraj Pal Kaur
    Matthew W. Eggert
    Lishann Ingram
    Deepraj Ghosh
    Sheela Sheth
    Tamas Nagy
    Michelle R. Dawson
    Robert D. Arnold
    Brian S. Cummings
    Scientific Reports, 9
  • [5] Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth
    Quach, Nhat D.
    Kaur, Sukhneeraj Pal
    Eggert, Matthew W.
    Ingram, Lishann
    Ghosh, Deepraj
    Sheth, Sheela
    Nagy, Tamas
    Dawson, Michelle R.
    Arnold, Robert D.
    Cummings, Brian S.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [6] Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1
    Fleming, FJ
    Myers, E
    Kelly, G
    Crotty, TB
    McDermott, EW
    O'Higgins, NJ
    Hill, ADK
    Young, LS
    JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (10) : 1069 - 1074
  • [7] Progression of prostate cancer to neuroendocrine cell tumor
    Tanaka, M
    Suzuki, Y
    Takaoka, K
    Suzuki, N
    Murakami, S
    Matsuzaki, O
    Shimazaki, J
    INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (08) : 431 - 436
  • [8] The Role of SRC-1 in Murine Prostate Carcinogenesis Is Nonessential due to a Possible Compensation of SRC-3/AIB1 Overexpression
    Tien, Jean Ching-Yi
    Zhou, Suoling
    Xu, Jianming
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2009, 5 (03): : 256 - 264
  • [9] A predictive role for Ets-2 and SRC-1 in endocrine resistant breast cancer
    Myers, E
    Hill, ADK
    McDermott, EW
    Higgins, NJO
    Young, LS
    BRITISH JOURNAL OF SURGERY, 2005, 92 (10) : 1302 - 1303
  • [10] Global analysis of the SRC-1 and HOXC-11 transcriptomes identifies a novel role for SRC-1 and HOXC-11 in suppressing luminal a markers in breast cancer
    Bolger, J. C.
    Walsh, C. A.
    McCartan, D. P.
    Cahalin, A.
    Hao, Y.
    Xu, J.
    O'Gaora, P.
    Hill, A. D.
    Young, L. S.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 9 - 9